首页> 美国卫生研究院文献>The Yale Journal of Biology and Medicine >Medical Grand Rounds: refractory hypertension and renal insufficiency in a patient with renal artery stenosis.
【2h】

Medical Grand Rounds: refractory hypertension and renal insufficiency in a patient with renal artery stenosis.

机译:医疗大回合:肾动脉狭窄患者的难治性高血压和肾功能不全。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Renal artery stenosis has become increasingly common as a cause of refractory hypertension and renal insufficiency. There is a high prevalence of bilateral disease and the lesions tend to progress over time. Newer, less invasive, imaging modalities such as doppler ultrasound, magnetic resonance angiography, and spiral CT scanning are evolving technologies in the diagnosis of renal artery stenosis. Advances in surgical technique, particularly the development of extra-anatomical procedures such as spleno-renal and hepato-renal by pass, have significantly lowered surgical morbidity and mortality and provides revascularization options for patients with complex vascular disease that would previously not have been considered because of their high surgical risk. Improvements in angioplasty technique and the use of stents are broadening the types of lesions that can be successfully approached with these techniques and may be particularly helpful for patients with more severe cardiac or cerebrovascular disease. The benefits of revascularization may be even greater for preservation of renal function than for control of blood pressure in properly selected patients. It is difficult to predict which patients will benefit from surgical revascularization versus medical management of RAS. Knowledge of the progressive nature of RAS, the high prevalence of bilateral disease, and the clinical characteristics that correlate with progression (e.g., decreasing renal size) are helpful in guiding clinical decisions regarding intervention. Additional studies to determine the predictive value of non-invasive tests such as CRS, doppler ultrasound before and after administration of angiotensin converting enzyme inhibitors, and other tests, are needed to assist the clinician in identifying who will benefit most from revascularization both in terms of renal function and blood pressure control.
机译:作为难治性高血压和肾功能不全的原因,肾动脉狭窄已变得越来越普遍。双边疾病的患病率很高,并且随着时间的流逝,病变会逐渐发展。诸如多普勒超声,磁共振血管造影和螺旋CT扫描等较新的,侵入性较小的成像方式正在发展为诊断肾动脉狭窄的技术。外科技术的进步,特别是诸如脾肾和肝肾旁穿刺等解剖外手术的发展,已显着降低了外科手术的发病率和死亡率,并为复杂血管疾病的患者提供了血运重建的选择,而以前由于这些原因,人们没有考虑过他们的高手术风险。血管成形术技术的改进和支架的使用拓宽了可以用这些技术成功治疗的病变类型,并且对于患有更严重的心脏或脑血管疾病的患者尤其有用。在适当选择的患者中,血运重建对肾脏功能的保护可能比控制血压的好处更大。与RAS的药物治疗相比,很难预测哪些患者将从血管重建术中受益。了解RAS的进行性,双边疾病的高发率以及与进展相关的临床特征(例如,肾脏大小缩小)有助于指导有关干预的临床决策。需要进行其他研究以确定无创性检查(如CRS,在应用血管紧张素转化酶抑制剂治疗前后的多普勒超声检查)的预测价值以及其他检查,以帮助临床医生确定谁将从血运重建中受益最大。肾功能和血压控制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号